SCHEMBL4725457

SCHEMBL4725457

c1ccc2nc3[nH]c(-c4cc5ccccc5[nH]4)cc3cc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.52
NPC1 O15118 3/20 0.52
PDE2A O00408 2/20 0.49
PDE3B Q13370 2/20 0.49
PDE3A Q14432 2/20 0.49
MAPT P10636 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 3/20 0.48
GLA P06280 1/20 0.48
ACHE P22303 1/20 0.48
ITK Q08881 2/20 0.46
CYP19A1 P11511 1/20 0.46
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 2/20 0.46
CASP3 P42574 2/20 0.46
KMT2A Q03164 2/20 0.46
SENP8 Q96LD8 2/20 0.46
SENP7 Q9BQF6 2/20 0.46
SENP6 Q9GZR1 2/20 0.46
KDR P35968 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776375 0.84 RAB9A (0.50) RAB9ANPC1PDE2APDE3BPDE3A
SCHEMBL374022 0.80 RAB9A (0.74) RAB9ANPC1MAPTALDH1A1HPGD
SCHEMBL29631691 0.80 RAB9A (0.74) RAB9ANPC1MAPTALDH1A1HPGD
SCHEMBL4725465 0.77 PDGFRB (0.55) PDE2APDE3BPDE3AMAPTALDH1A1
SCHEMBL4794773 0.76 GSK3B (0.60) RAB9ANPC1ITKCYP19A1GSK3B
SCHEMBL5423443 0.76 NPC1 (0.58) RAB9ANPC1MAPTALDH1A1HPGD
SCHEMBL2186023 0.75 RAB9A (0.57) RAB9ANPC1MAPTALDH1A1HPGD
SCHEMBL4780727 0.75 RIPK1 (0.59) RAB9ANPC1ITKCYP19A1GSK3B
SCHEMBL31603909 0.75 KDR (0.54) RAB9ANPC1MAPTALDH1A1HPGD
SCHEMBL14012751 0.75 KDR (0.54) RAB9ANPC1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008014249-A2 IMPROVED PREPARATIONS OF 2 -SUBSTITUTED PYRROLO [2, 3-B] PYRAZINE ( 4, 7 -DIAZAINDOLE ) COMPOUNDS SANOFI-AVENTIS (FR) 2008-01-31 WO disclosed